-- バイオ燃料原料先物価格は上昇して取引を終え、大豆関連先物価格が上昇を牽引した。これは、週末に中東和平協議が再び中止されたにもかかわらずのことである。 シカゴ商品取引所(CBOT)の7月限大豆先物契約は1.15%高の1ブッシェル当たり11.92ドルで引け、7月限大豆油先物契約は0.48%高の1ポンド当たり71.67セントで引けた。 月曜日、ニューヨーク・マーカンタイル取引所(NYMEX)の6月限エタノール先物契約は1.66%高の1ガロン当たり1.99ドルで取引を終えた。 DTNのアナリスト、レット・モンゴメリー氏は、大豆市場は米国とイランの和平協議の停滞を無視したと述べた。 「月曜日に大豆ミール先物価格が急騰したが、これはスプレッド取引の結果である可能性が高い。大豆油が2026年までの圧搾価格において歴史的に大きな割合を占めており、トレーダーたちはその一部を調整しようとしていると考えられる」とモンゴメリー氏は日報で述べた。 同氏はさらに、ブラジルの記録的な豊作により、市場参加者は中国が米国産大豆を購入する必要がないと考えていると付け加えた。「しかし、来月の会合で何らかの合意が成立する可能性は否定できず、世界の大豆需要という観点から見ると、この会合は現在市場にとって最も重要なイベントである」と述べた。 月曜日に発表された米国農務省の週間輸出検査報告書によると、4月23日までの週の大豆予約量は2310万ブッシェルだった。2025~2026年の総検査量は12億600万ブッシェルで、前年比20%減となっている。 米国農務省(USDA)は、2025~2026年度の大豆輸出量を15億4000万バレルと予測しており、これは前年度比18%減となる。大豆の検査はUSDAの予測ペースを下回っており、一方でUSDAが予測する大豆期末在庫は過去5年間の平均を20%上回っている。
Related Articles
Research Alert: Universal Health Services: Q1 Eps Tops Estimates
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:UHS delivered solid Q1 results, with adjusted EPS of $5.62 (up 16.1% Y/Y), $0.16 above consensus, while revenue grew 9.6% to $4.495B due to higher prices despite modest patient volumes. Same-facility acute care revenue increased 8.2% on flat adjusted admissions but 6.3% growth in revenue per admission, while behavioral health saw 1.2% admission growth and 7.3% revenue growth. We think the $835M Talkspace acquisition may expand UHS's virtual behavioral health capabilities and broaden payor mix. Management expects the deal to close in Q3. Operating cash flow improved 11.7% to $402M, and UHS repurchased $127.3M in stock, though adjusted EBITDA margin compressed 20 bps to 14.4% on higher operating expenses. We think behavioral health staffing challenges persist but expect the Talkspace integration to create growth opportunities.
Research Alert: Cls Q1: Blistering Fy 26 Guidance And Cpo Win Tempered By Capital Demands
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Q1 revenues of $4.05B (+53%) and adjusted EPS of $2.16 (+80%) both exceeded guidance on accelerating hyperscaler demand. Adjusted operating margin reached a record 8.0%, due to higher-value CCS offerings, which grew 76% to $3.24B, with segment margin expanding to 8.6%. The company secured a new CPO switch program with a hyperscaler customer expected to ramp in 2027, and we expect more color tomorrow. Management raised 2026 guidance to $19.0B revenue (from $17.0B) and $10.15 adjusted EPS (from $8.75), representing over $6.5B in revenue growth. Stronger growth is anticipated for 2027 based on improved customer visibility and new program wins. The company enlarged its balance sheet by upsizing its credit facility to $2.5B, with revolver capacity increased to $1.75B. FCF of $137.9M remained robust despite elevated capex of $218.4M to support capacity expansion. Share buybacks slowing, FCF guidance lagging, and a +50% month may be contributing to the after-hours selloff.
Research Alert: Avalonbay Communities Q1 2026: Slight Ffo Beat, But Flat Cash Noi
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:AVB reported Q1 2026 results with FFO at $2.83, flat Y/Y but $0.03 above consensus. Rental revenue rose 3.3% Y/Y while operating expenses surged 4.7%, resulting in weak same-store NOI growth of just 0.2% Y/Y. Same-store occupancy was flat at 96.1% vs. 96.0% a year ago, and turnover decreased to 31.6% from 32.1%. We like AVB's portfolio profile, with 80% exposure to premier East Coast (35%) and West Coast (45%) markets. We are monitoring the 20% Sun Belt allocation, which faces new supply pressures. The trust is guiding Q2 2026 FFO of $2.72-$2.82 per share, with full-year 2026 same-store NOI ranging from -0.7% to +1.3%. AVB has $3.39B in community developments underway that target suburban markets. We think total debt of $9.4B is manageable. Utility expenses surged 12.5% Y/Y in New England and Mid-Atlantic markets, reflecting ongoing inflationary pressures. Despite these cost headwinds, we believe there's financial flexibility to fund the development pipeline in high-barrier-to-entry coastal markets.